0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-23p19 Inhibitors Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-23R18295
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 23p19 Inhibitors Market Research Report 2024
BUY CHAPTERS

Global IL-23p19 Inhibitors Market Research Report 2026

Code: QYRE-Auto-23R18295
Report
2026-01-19
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IL-23p19 Inhibitors Market Size

The global IL-23p19 Inhibitors market was valued at US$ 20480 million in 2025 and is anticipated to reach US$ 56400 million by 2032, at a CAGR of 15.8% from 2026 to 2032.

IL-23p19 Inhibitors Market

IL-23p19 Inhibitors Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on IL-23p19 Inhibitors competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
IL-23p19 inhibitors are a class of drugs that work by inhibiting the biological activity of Interleukin-23 (IL-23). IL-23 is a cytokine composed of two subunits, p40 and p19, of which p19 is the specific subunit of IL-23。The mechanism of action of IL-23p19 inhibitors is to prevent IL-23 from binding to its receptor by specifically binding to the p19 subunit of IL-23, thereby disrupting IL-23-mediated signaling pathways and reducing the production of inflammatory factors, such as IL-17, IL-22 and GM-CSF. These factors play an important role in chronic inflammatory diseases.
The North American market for IL-23p19 Inhibitors is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for IL-23p19 Inhibitors is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of IL-23p19 Inhibitors include Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global IL-23p19 Inhibitors market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding IL-23p19 Inhibitors. The IL-23p19 Inhibitors market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global IL-23p19 Inhibitors market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist IL-23p19 Inhibitors manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of IL-23p19 Inhibitors Market Report

Report Metric Details
Report Name IL-23p19 Inhibitors Market
Accounted market size in 2025 US$ 20480 million
Forecasted market size in 2032 US$ 56400 million
CAGR 15.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 100mg/mL
  • 75mg/mL
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for IL-23p19 Inhibitors manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines IL-23p19 Inhibitors sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is IL-23p19 Inhibitors Market growing?

Ans: The IL-23p19 Inhibitors Market witnessing a CAGR of 15.8% during the forecast period 2026-2032.

What is the IL-23p19 Inhibitors Market size in 2032?

Ans: The IL-23p19 Inhibitors Market size in 2032 will be US$ 56400 million.

Who are the main players in the IL-23p19 Inhibitors Market report?

Ans: The main players in the IL-23p19 Inhibitors Market are Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson

What are the Application segmentation covered in the IL-23p19 Inhibitors Market report?

Ans: The Applications covered in the IL-23p19 Inhibitors Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the IL-23p19 Inhibitors Market report?

Ans: The Types covered in the IL-23p19 Inhibitors Market report are 100mg/mL, 75mg/mL

1 IL-23p19 Inhibitors Market Overview
1.1 Product Definition
1.2 IL-23p19 Inhibitors by Type
1.2.1 Global IL-23p19 Inhibitors Market Value by Type: 2025 vs 2032
1.2.2 100mg/mL
1.2.3 75mg/mL
1.3 IL-23p19 Inhibitors by Application
1.3.1 Global IL-23p19 Inhibitors Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global IL-23p19 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global IL-23p19 Inhibitors Revenue 2021–2032
1.4.2 Global IL-23p19 Inhibitors Sales 2021–2032
1.4.3 Global IL-23p19 Inhibitors Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 IL-23p19 Inhibitors Market Competition by Manufacturers
2.1 Global IL-23p19 Inhibitors Sales Market Share by Manufacturers (2021–2026)
2.2 Global IL-23p19 Inhibitors Revenue Market Share by Manufacturers (2021–2026)
2.3 Global IL-23p19 Inhibitors Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of IL-23p19 Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of IL-23p19 Inhibitors, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of IL-23p19 Inhibitors, Product Types and Applications
2.7 Global Key Manufacturers of IL-23p19 Inhibitors, Date of Entry into the Industry
2.8 Global IL-23p19 Inhibitors Market Competitive Situation and Trends
2.8.1 Global IL-23p19 Inhibitors Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global IL-23p19 Inhibitors Players Market Share by Revenue
2.8.3 Global IL-23p19 Inhibitors Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-23p19 Inhibitors Market Scenario by Region
3.1 Global IL-23p19 Inhibitors Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global IL-23p19 Inhibitors Sales by Region: 2021–2032
3.2.1 Global IL-23p19 Inhibitors Sales by Region: 2021–2026
3.2.2 Global IL-23p19 Inhibitors Sales by Region: 2027–2032
3.3 Global IL-23p19 Inhibitors Revenue by Region: 2021–2032
3.3.1 Global IL-23p19 Inhibitors Revenue by Region: 2021–2026
3.3.2 Global IL-23p19 Inhibitors Revenue by Region: 2027–2032
3.4 North America IL-23p19 Inhibitors Market Facts & Figures by Country
3.4.1 North America IL-23p19 Inhibitors Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America IL-23p19 Inhibitors Sales by Country (2021–2032)
3.4.3 North America IL-23p19 Inhibitors Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-23p19 Inhibitors Market Facts & Figures by Country
3.5.1 Europe IL-23p19 Inhibitors Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe IL-23p19 Inhibitors Sales by Country (2021–2032)
3.5.3 Europe IL-23p19 Inhibitors Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-23p19 Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific IL-23p19 Inhibitors Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific IL-23p19 Inhibitors Sales by Region (2021–2032)
3.6.3 Asia Pacific IL-23p19 Inhibitors Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-23p19 Inhibitors Market Facts & Figures by Country
3.7.1 Latin America IL-23p19 Inhibitors Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America IL-23p19 Inhibitors Sales by Country (2021–2032)
3.7.3 Latin America IL-23p19 Inhibitors Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-23p19 Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-23p19 Inhibitors Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa IL-23p19 Inhibitors Sales by Country (2021–2032)
3.8.3 Middle East and Africa IL-23p19 Inhibitors Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-23p19 Inhibitors Sales by Type (2021–2032)
4.1.1 Global IL-23p19 Inhibitors Sales by Type (2021–2026)
4.1.2 Global IL-23p19 Inhibitors Sales by Type (2027–2032)
4.1.3 Global IL-23p19 Inhibitors Sales Market Share by Type (2021–2032)
4.2 Global IL-23p19 Inhibitors Revenue by Type (2021–2032)
4.2.1 Global IL-23p19 Inhibitors Revenue by Type (2021–2026)
4.2.2 Global IL-23p19 Inhibitors Revenue by Type (2027–2032)
4.2.3 Global IL-23p19 Inhibitors Revenue Market Share by Type (2021–2032)
4.3 Global IL-23p19 Inhibitors Price by Type (2021–2032)
5 Segment by Application
5.1 Global IL-23p19 Inhibitors Sales by Application (2021–2032)
5.1.1 Global IL-23p19 Inhibitors Sales by Application (2021–2026)
5.1.2 Global IL-23p19 Inhibitors Sales by Application (2027–2032)
5.1.3 Global IL-23p19 Inhibitors Sales Market Share by Application (2021–2032)
5.2 Global IL-23p19 Inhibitors Revenue by Application (2021–2032)
5.2.1 Global IL-23p19 Inhibitors Revenue by Application (2021–2026)
5.2.2 Global IL-23p19 Inhibitors Revenue by Application (2027–2032)
5.2.3 Global IL-23p19 Inhibitors Revenue Market Share by Application (2021–2032)
5.3 Global IL-23p19 Inhibitors Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly IL-23p19 Inhibitors Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly IL-23p19 Inhibitors Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie IL-23p19 Inhibitors Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie IL-23p19 Inhibitors Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Merck Sharp & Dohme Corp.
6.3.1 Merck Sharp & Dohme Corp. Company Information
6.3.2 Merck Sharp & Dohme Corp. Description and Business Overview
6.3.3 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolio
6.3.5 Merck Sharp & Dohme Corp. Recent Developments/Updates
6.4 Innovent Biologics (Suzhou) Co. Ltd.
6.4.1 Innovent Biologics (Suzhou) Co. Ltd. Company Information
6.4.2 Innovent Biologics (Suzhou) Co. Ltd. Description and Business Overview
6.4.3 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolio
6.4.5 Innovent Biologics (Suzhou) Co. Ltd. Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson IL-23p19 Inhibitors Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson & Johnson IL-23p19 Inhibitors Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-23p19 Inhibitors Industry Chain Analysis
7.2 IL-23p19 Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-23p19 Inhibitors Production Mode & Process Analysis
7.4 IL-23p19 Inhibitors Sales and Marketing
7.4.1 IL-23p19 Inhibitors Sales Channels
7.4.2 IL-23p19 Inhibitors Distributors
7.5 IL-23p19 Inhibitors Customer Analysis
8 IL-23p19 Inhibitors Market Dynamics
8.1 IL-23p19 Inhibitors Industry Trends
8.2 IL-23p19 Inhibitors Market Drivers
8.3 IL-23p19 Inhibitors Market Challenges
8.4 IL-23p19 Inhibitors Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global IL-23p19 Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global IL-23p19 Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global IL-23p19 Inhibitors Market Competitive Situation by Manufacturers in 2025
 Table 4. Global IL-23p19 Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global IL-23p19 Inhibitors Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global IL-23p19 Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global IL-23p19 Inhibitors Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market IL-23p19 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of IL-23p19 Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of IL-23p19 Inhibitors, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of IL-23p19 Inhibitors, Product Types and Applications
 Table 12. Global Key Manufacturers of IL-23p19 Inhibitors, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-23p19 Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-23p19 Inhibitors Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-23p19 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global IL-23p19 Inhibitors Sales by Region (K Units), 2021–2026
 Table 18. Global IL-23p19 Inhibitors Sales Market Share by Region (2021–2026)
 Table 19. Global IL-23p19 Inhibitors Sales by Region (K Units), 2027–2032
 Table 20. Global IL-23p19 Inhibitors Sales Market Share by Region (2027–2032)
 Table 21. Global IL-23p19 Inhibitors Revenue by Region (US$ Million), 2021–2026
 Table 22. Global IL-23p19 Inhibitors Revenue Market Share by Region (2021–2026)
 Table 23. Global IL-23p19 Inhibitors Revenue by Region (US$ Million), 2027–2032
 Table 24. Global IL-23p19 Inhibitors Revenue Market Share by Region (2027–2032)
 Table 25. North America IL-23p19 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America IL-23p19 Inhibitors Sales by Country (K Units), 2021–2026
 Table 27. North America IL-23p19 Inhibitors Sales by Country (K Units), 2027–2032
 Table 28. North America IL-23p19 Inhibitors Revenue by Country (US$ Million), 2021–2026
 Table 29. North America IL-23p19 Inhibitors Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe IL-23p19 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe IL-23p19 Inhibitors Sales by Country (K Units), 2021–2026
 Table 32. Europe IL-23p19 Inhibitors Sales by Country (K Units), 2027–2032
 Table 33. Europe IL-23p19 Inhibitors Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe IL-23p19 Inhibitors Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific IL-23p19 Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific IL-23p19 Inhibitors Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific IL-23p19 Inhibitors Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific IL-23p19 Inhibitors Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific IL-23p19 Inhibitors Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America IL-23p19 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America IL-23p19 Inhibitors Sales by Country (K Units), 2021–2026
 Table 42. Latin America IL-23p19 Inhibitors Sales by Country (K Units), 2027–2032
 Table 43. Latin America IL-23p19 Inhibitors Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America IL-23p19 Inhibitors Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa IL-23p19 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa IL-23p19 Inhibitors Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa IL-23p19 Inhibitors Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa IL-23p19 Inhibitors Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa IL-23p19 Inhibitors Revenue by Country (US$ Million), 2027–2032
 Table 50. Global IL-23p19 Inhibitors Sales (K Units) by Type (2021–2026)
 Table 51. Global IL-23p19 Inhibitors Sales (K Units) by Type (2027–2032)
 Table 52. Global IL-23p19 Inhibitors Sales Market Share by Type (2021–2026)
 Table 53. Global IL-23p19 Inhibitors Sales Market Share by Type (2027–2032)
 Table 54. Global IL-23p19 Inhibitors Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global IL-23p19 Inhibitors Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global IL-23p19 Inhibitors Revenue Market Share by Type (2021–2026)
 Table 57. Global IL-23p19 Inhibitors Revenue Market Share by Type (2027–2032)
 Table 58. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2021–2026)
 Table 59. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2027–2032)
 Table 60. Global IL-23p19 Inhibitors Sales (K Units) by Application (2021–2026)
 Table 61. Global IL-23p19 Inhibitors Sales (K Units) by Application (2027–2032)
 Table 62. Global IL-23p19 Inhibitors Sales Market Share by Application (2021–2026)
 Table 63. Global IL-23p19 Inhibitors Sales Market Share by Application (2027–2032)
 Table 64. Global IL-23p19 Inhibitors Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global IL-23p19 Inhibitors Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global IL-23p19 Inhibitors Revenue Market Share by Application (2021–2026)
 Table 67. Global IL-23p19 Inhibitors Revenue Market Share by Application (2027–2032)
 Table 68. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2021–2026)
 Table 69. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2027–2032)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Eli Lilly IL-23p19 Inhibitors Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. AbbVie IL-23p19 Inhibitors Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Merck Sharp & Dohme Corp. Company Information
 Table 81. Merck Sharp & Dohme Corp. Description and Business Overview
 Table 82. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product
 Table 84. Merck Sharp & Dohme Corp. Recent Developments/Updates
 Table 85. Innovent Biologics (Suzhou) Co. Ltd. Company Information
 Table 86. Innovent Biologics (Suzhou) Co. Ltd. Description and Business Overview
 Table 87. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product
 Table 89. Innovent Biologics (Suzhou) Co. Ltd. Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Johnson & Johnson IL-23p19 Inhibitors Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. IL-23p19 Inhibitors Distributors List
 Table 98. IL-23p19 Inhibitors Customers List
 Table 99. IL-23p19 Inhibitors Market Trends
 Table 100. IL-23p19 Inhibitors Market Drivers
 Table 101. IL-23p19 Inhibitors Market Challenges
 Table 102. IL-23p19 Inhibitors Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-23p19 Inhibitors
 Figure 2. Global IL-23p19 Inhibitors Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global IL-23p19 Inhibitors Market Share by Type: 2025 & 2032
 Figure 4. 100mg/mL Product Picture
 Figure 5. 75mg/mL Product Picture
 Figure 6. Global IL-23p19 Inhibitors Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global IL-23p19 Inhibitors Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global IL-23p19 Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global IL-23p19 Inhibitors Market Size (US$ Million), 2021–2032
 Figure 13. Global IL-23p19 Inhibitors Sales (K Units), 2021–2032
 Figure 14. Global IL-23p19 Inhibitors Average Price (US$/Unit), 2021–2032
 Figure 15. IL-23p19 Inhibitors Report Years Considered
 Figure 16. IL-23p19 Inhibitors Sales Share by Manufacturers in 2025
 Figure 17. Global IL-23p19 Inhibitors Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global IL-23p19 Inhibitors Players: Market Share by Revenue in IL-23p19 Inhibitors in 2025
 Figure 19. IL-23p19 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global IL-23p19 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America IL-23p19 Inhibitors Sales Market Share by Country (2021–2032)
 Figure 22. North America IL-23p19 Inhibitors Revenue Market Share by Country (2021–2032)
 Figure 23. United States IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe IL-23p19 Inhibitors Sales Market Share by Country (2021–2032)
 Figure 26. Europe IL-23p19 Inhibitors Revenue Market Share by Country (2021–2032)
 Figure 27. Germany IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific IL-23p19 Inhibitors Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific IL-23p19 Inhibitors Revenue Market Share by Region (2021–2032)
 Figure 34. China IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America IL-23p19 Inhibitors Sales Market Share by Country (2021–2032)
 Figure 42. Latin America IL-23p19 Inhibitors Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa IL-23p19 Inhibitors Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa IL-23p19 Inhibitors Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE IL-23p19 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of IL-23p19 Inhibitors by Type (2021–2032)
 Figure 53. Global Revenue Market Share of IL-23p19 Inhibitors by Type (2021–2032)
 Figure 54. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of IL-23p19 Inhibitors by Application (2021–2032)
 Figure 56. Global Revenue Market Share of IL-23p19 Inhibitors by Application (2021–2032)
 Figure 57. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2021–2032)
 Figure 58. IL-23p19 Inhibitors Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India